Can patient-reported outcomes and inflammatory markers define endotype 2 in chronic rhinosinusitis without nasal polyps?

M Plath, L Derycke, M Sand, D Van de Vyvere… - Annals of Allergy …, 2023 - Elsevier
Background Chronic rhinosinusitis (CRS) is a heterogeneous disease at the clinical
phenotype level (without nasal polyp [CRSsNP] vs with nasal polyp [CRSwNP]) and at the …
被引用次数：4 相关文章

Can patient-reported outcomes and inflammatory markers define endotype 2 in chronic rhinosinusitis without nasal polyps?

M Plath, L Derycke, M Sand… - … ALLERGY ASTHMA & …, 2023 - iris.uniroma1.it
Background: Chronic rhinosinusitis (CRS) is a heterogeneous disease at the clinical
phenotype level (without nasal polyp [CRSsNP] vs with nasal polyp [CRSwNP]) and at the …

Can patient-reported outcomes and inflammatory markers define endotype 2 in chronic rhinosinusitis without nasal polyps?

M Plath, L Derycke, M Sand… - Annals of Allergy …, 2023 - annallergy.org
Background Chronic rhinosinusitis (CRS) is a heterogeneous disease at the clinical
phenotype level (without nasal polyp [CRSsNP] vs with nasal polyp [CRSwNP]) and at the …

Can patient-reported outcomes and inflammatory markers define endotype 2 in chronic rhinosinusitis without nasal polyps?

M Plath, L Derycke, M Sand… - Annals of allergy …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Chronic rhinosinusitis (CRS) is a heterogeneous disease at the clinical
phenotype level (without nasal polyp [CRSsNP] vs with nasal polyp [CRSwNP]) and at the …

Can Patient-Reported Outcomes and Inflammatory Markers define Endotype 2 in Chronic Rhinosinusitis without Nasal Polyps?

M Plath, L Derycke, M Sand, DV de Vyvere… - Annals of Allergy …, 2022 - europepmc.org
Chronic rhinosinusitis (CRS) is a heterogeneous disease at the clinical phenotype level
(CRSsNP (without nasal polyps) vs. CRSwNP (with nasal polyps)), but also at the underlying …